Merck to collaborate with GenScript to accelerate cell and gene therapy industrialization in China
Merck, a leading science and technology company, today announced the signing of a non-binding Memorandum of Understanding with Chinese biotech company GenScript for a strategic alliance focusing on plasmid and viral vector manufacturing.
Source: World Pharma News - Category: Pharmaceuticals Tags: Featured Merck Group Business and Industry Source Type: news
More News: Biotechnology | China Health | Gene Therapy | Genetics | Merck | Pharmaceuticals | Science